This chapter discusses how nanoparticles and multimodal nano-imaging are
bringing closer to the moment where imaging and therapy converge. This means that
the diagnosed illnesses can be treated in situ based on the imaging result allowing
personalized Nano-medicine. There are already theranostic nano-medicines that can do
precise drug delivery only to the targets that are seen and approved by radiology and
nuclear medicine tools. In this chapter, we also discuss the already existing emerging
techniques and their challenges and implications on the traditional pharma industry and
startup-driven biobusiness.
Keywords: Drug delivery, Multimodal Imaging, Nanoimaging, Nanomedicine, Theranostic.
